Meso Numismatics reports positive operating cash flow >$100k in Q1 2024; proceeding with name change to RMTG

Regenerative Medical Technology Group Inc.

Name change to Regenerative Medical Technology Group Inc. pending FINRA market effective date.
Positive cash from operations over $100k for the quarter ended March 31, 2024, per recent 10-Q.
New logo and authorized shares change near completion to reflect biotech focus.
Company transitions from numismatics to regenerative medicine, now a stem cell company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.